|
马志强,教授,青年##,课题组长。2007年毕业于中科院上海有机化学研究所,获博士学位;随后在美国德克萨斯大学西南医学中心进行博士后研究,主要致力于吡咯-咪唑生物碱的合成研究;2016年入职华南理工大学。期间发表论文18篇,他引次数600多次,部分研究成果以第一作者身份发表在《Science》、《Angew. Chem. Int. Ed》、《Chem. Commun》等主流学术刊物。2017年入选国家第十三批“青年##计划”。
联系地址:广州市天河区五山路381号,邮编:510641
联系人:马志强
Tel:020-22236303
Email: cezqma@scut.edu.cn
代表性论文:
1. Zhiqiang Ma#, Xiaolei Wang#, Xiao Wang, Rodrigo A. Rodriguez, Curtis E. Moore, Shuanhu Gao, Xianghui Tan, Yuyong Ma, Arnold L. Rheingold, Phil S. Baran, Chuo Chen*, Asymmetric Syntheses of Sceptrin and Massadine and Evidence for Biosynthetic Enantiodivergence, Science 2014, 346, 219–224. (# co-first author)
2. Zhiqiang Ma, Xiao Wang, Yuyong Ma, Chuo Chen*, Asymmetric Synthesis of Axinellamines A and B, Angew. Chem. Int. Ed. 2016, 55, 4763–4766.
3. Pengquan Chen, Yuecheng Wu, Shifa Zhu, Huanfeng Jiang, Zhiqiang Ma*, Ir-Catalyzed Reactions in Natural Product Synthesis, Org. Chem. Front., 2017, DOI: 10.1039/c7qo00665a.
4. Jiuzhong Huang, Jia Zheng, Wanqing Wu, Jianxiao Li, Zhiqiang Ma*, Yanwei Ren, Huanfeng Jiang*, Palladium-Catalyzed Intermolecular Oxidative Cyclization of Allyltosylamides with AcOH: Assembly of 3 Pyrrolin-2-ones, J. Org. Chem. 2017, 82, 8191−8198
5. Zhiqiang Ma, Lin You, Chuo Chen*, Stereocontrolled Formation of a [4.4]Heterospiro Ring System with Unexpected Inversion of Configuration at the Spirocenter, J. Org. Chem. 2017, 82, 731−736.
6. Zhiqiang Ma, Jianming Lu, Xiao Wang, Chuo Chen*, Revisiting the Kinnel−Scheuer hypothesis for the biosynthesis of palau'amine, Chem. Commun. 2011, 47, 427−429.
7. Zhiqiang Ma, Bin Cheng, Hongbin Zhai*, Synthetic Studies toward Harringtonolide, Asian J. Org. Chem. 2014, 3, 1097–1101.
8. Zhiqiang Ma, Hanwei Hu, Wanting Xiong, Hongbin Zhai*, Concise Formal Syntheses of (-)-Aphanorphine and Unnatural (+)-Aphanorphine from (2S,4R)-4-Hydroxyproline, Tetrahedron 2007, 63, 7523–7531.
9. Zhiqiang Ma, Hongbin Zhai*, Concise Formal Synthesis of Unnatural (+)-Aphanorphine from (2S,4R)-4-Hydroxyproline, Synlett 2007, 161–163.
|
声明:本网部分文章和图片来源于网络,发布的文章仅用于材料专业知识和市场资讯的交流与分享,不用于任何商业目的。任何个人或组织若对文章版权或其内容的真实性、准确性存有疑义,请第一时间联系我们,我们将及时进行处理。
|